Time-dependent risk factors associated with the decline of estimated GFR in CKD patients

Wen-xiu Chang1,2, Shigeyuki Arai1, Yoshifuru Tamura1

  • 1Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo, 173-8605, Japan.

Insights

Time-averaged analysis reveals key risk factors for chronic kidney disease (CKD) progression. Hyperphosphatemia, proteinuria, and anemia are strongly linked to rapid decline in estimated glomerular filtration rate (eGFR).

Area of Science:

  • Nephrology
  • Clinical Epidemiology

Background:

  • Chronic kidney disease (CKD) progression is influenced by modifiable risk factors.
  • Analyzing risk factors using follow-up parameters is crucial for effective management.
  • Understanding time-dependent risk factors can help halt CKD progression.

Purpose of the Study:

  • To examine time-dependent risk factors for CKD progression using time-averaged values.
  • To identify characteristics of patients experiencing rapid CKD progression.

Main Methods:

  • Retrospective cohort study of 770 patients with CKD stage 3-4.
  • Calculation of time-dependent parameters using time-averaged values.
  • Classification of estimated glomerular filtration rate (eGFR) decline into stable, moderate, and rapid progression groups.
  • Multivariate regression analyses on baseline and time-averaged datasets.

Main Results:

  • eGFR decline was significantly higher in males than females.
  • % decline of eGFR was associated with male sex, proteinuria, phosphorus, and systolic blood pressure.
  • Rapid CKD progression was linked to proteinuria, phosphorus, albumin, and hemoglobin in follow-up data.

Conclusions:

  • Time-averaged values offer valuable clinical insights for targeting risk factors in CKD.
  • Hyperphosphatemia, proteinuria, and anemia are critical targets for intervention in CKD management.
  • Early intervention for these factors may slow the progression of chronic kidney disease.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
311
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
323
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
110
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.5K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
324
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K